Size: 5mg
Contents: Dermorphin (5mg)
Form: Lyophilized powder
Purity: >99%
Out of stock
Dermorphin 5mg is a high-purity, research-grade heptapeptide recognized for its exceptional potency and selectivity as a mu-opioid receptor (MOR) agonist. Originally isolated from Phyllomedusa species, this peptide features a unique structural profile, including a rare D-alanine residue, making it a powerful and precise tool for advanced opioid receptor research.
Developed exclusively for in-vitro and preclinical applications, Dermorphin 5mg is widely utilized in studies focused on receptor binding, neuropeptide signaling, and pain pathway modulation in controlled laboratory environments.
Dermorphin stands out among opioid peptides for its remarkable affinity and selectivity toward mu-opioid receptors. This makes it a preferred reference compound in receptor binding assays and pharmacological investigations where precision and specificity are critical.
Its consistent purity and well-characterized structure enable researchers to generate reliable, reproducible data across a wide range of experimental models in neuropharmacology and peptide science.
Dermorphin 5mg is widely recognized in research for its strong interaction with mu-opioid receptors and its ability to selectively activate MOR-mediated signaling pathways.
Researchers studying pain modulation, receptor pharmacodynamics, and neuropeptide interactions rely on Dermorphin for its potency and specificity. Its unique structure allows for detailed analysis of receptor selectivity, signal transduction, and ligand-receptor dynamics.
Peptide Type: Opioid peptide (heptapeptide)
Compound: Dermorphin
Source: Naturally derived from Phyllomedusa species
Target Receptor: Mu-opioid receptor (MOR)
Primary Function: Opioid receptor binding and signaling research
Dermorphin 5mg functions by binding selectively to mu-opioid receptors, triggering intracellular signaling pathways associated with opioid receptor activation.
Its structural uniqueness, particularly the presence of a D-alanine residue, enhances receptor binding affinity and resistance to enzymatic degradation. This results in strong and sustained receptor interaction, making it ideal for studying opioid signaling mechanisms and receptor dynamics.
These properties allow researchers to investigate MOR-specific pathways with a high degree of precision in controlled research settings.
Dermorphin 5mg is widely utilized in laboratory studies focused on:
Its high potency and receptor specificity make it an essential compound for advanced opioid and neuropharmacological research.
In controlled research environments, Dermorphin has demonstrated strong and selective activity at mu-opioid receptors, making it a valuable reference ligand in opioid research.
Studies highlight its usefulness in exploring receptor signaling pathways, ligand specificity, and comparative pharmacology with other opioid compounds. Its distinct molecular profile continues to support advancements in neuropeptide and receptor-based research.
Product Name: Dermorphin
Quantity: 5mg per vial
Form: Lyophilized powder
Purity: ≥99%
Store Dermorphin 5mg in a cool, dry place away from direct light. Refrigeration is recommended to maintain stability, especially after reconstitution in research settings.
Dermorphin 5mg is intended strictly for research and laboratory use only.
It is not approved for human consumption, veterinary use, or therapeutic applications.
All handling must be performed by qualified professionals in compliance with applicable laws and regulations.
